Pathways for the bradykinin B1 receptor-mediated diabetic hyperalgesia in mice

Inflammation Research

Volumn 53, Issue 12, 2004, Pages 653-657

  Gabra, B H ^a   Sirois, P ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Bradykinin B1 receptors; Calcitonin gene related peptide; Hyperalgesia; Kinins; Nitric oxide; Substance P; Type 1 diabetes

Indexed keywords

BRADYKININ B1 RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; N ACETYLTRYPTOPHAN 3,5 BIS(TRIFLUOROMETHYL)BENZYL ESTER; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; STREPTOZOCIN; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE; SUBSTANCE P;

ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG POTENTIATION; HOT PLATE TEST; HYPERALGESIA; IMMERSION; MOUSE; NOCICEPTION; NONHUMAN; STREPTOZOCIN DIABETES; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; MALE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HYPERALGESIA; MALE; MICE; NITRIC OXIDE SYNTHASE; RECEPTOR, BRADYKININ B1; SIGNAL TRANSDUCTION; STREPTOZOCIN; SUBSTANCE P;

EID: 12944302110     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-004-1310-0     Document Type: Article

References (12)

1. Coderre TJ, Rollman GB. Naloxone hyperalgesia and stress-induced analgesia in rats. Life Sci 1983; 32: 2139-46.
2. Couture R, Harrisson M, Vianna RM, Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 2001; 429: 161-76.
3. Dray A, Perkins MN. Kinins and pain. In: Farmeer S, editor. The Kinin System. Academic Press, San Diego, 1997: 157-72.
4. Eddy NP, Leimbach D. Synthetic analgesics (II), dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther 1953; 107: 385-9.
5. 1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice. Eur J Pharmacol 2002; 457: 115-24.
6. 1 receptor antagonists inhibit diabetes-mediated hyperalgesia in mice. Neuropeptides 2003; 37: 36-44.
7. 1 receptors for kinins. Pharmacol Rev 1998; 50: 357-86.
8. McEvoy RC, Andersson J, Sandler S, Hellerstrom C. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. J Clin Invest 1984; 74: 715-22.
9. 1 Receptor Antagonist, R-954, on Enhanced Vascular Permeability in Type 1 Diabetic Mice. Can J Physiol Pharmacol 2002; 80: 1203-7.
10. Walker K, Perkins M, Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int 1995; 26: 1-16.
11. 2 kinin receptor antagonists in diabetic mice. Can J Physiol Pharmacol 1996; 74: 586-9.
12. Zuccollo A, Navarro M, Frontera M, Cueva F, Carattino M, Catanzaro O. The involvement of kallikrein-kinin system in diabetes type 1 (insulitis). Immunopharamacology 1999; 45: 69-74.